Panacea Biotech

Why Panacea Biotec shares were locked in 5% upper circuit on Thursday?

As per the company's filing, the United Nations International Children's Emergency Fund (UNICEF) awarded the company to supply 115 million doses of bivalent oral polio vaccine (bOPV) in Africa/Asia

DFC commits long-term loan of $20 mn to Panacea Biotec to expand operations

US International Development Finance Corporation (DFC) has committed a long-term loan of up to USD 20 million to Panacea Biotec, the company said on Thursday. Panacea is expanding the manufacturing capacity for drug substance antigens used in its hexavalent vaccine EasySix to meet future demand from UN agencies and public health organisations. DFC has agreed to provide a long-term loan of up to USD 20 million to the company to help finance this project, the biotechnology firm said in a regulatory filing. DFC's financing will enable Panacea Biotec to expedite the completion of the ongoing expansion and supply the hexavalent vaccine to UN agencies for childhood immunisation globally, it added. "Our hexavalent vaccine EasySix, which meets the highest standards of safety and efficacy, will have a meaningful impact on the lives of millions of newborns in the developing world," Panacea Biotec Chairman and MD Rajesh Jain said. DFC Deputy CEO Nisha Biswal said the organisation's partnersh

Panacea Biotec freezes in 10% upper circuit; stock zooms 101% in 1 month

A combined 2.1 million equity shares of the company had changed hands till 02:50 PM, and there are pending buy orders for nearly 100,000 shares on the NSE and BSE.

Panacea Biotec up 5% as Co begins producing Sputnik V vaccine in India

Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Panacea Biotech announced the launch of production of the Russian Sputnik V vaccine against coronavirus

Adar Poonawalla exits Panacea Biotec; sells entire stake for Rs 118 cr

Serum Institute of India CEO Adar Poonawalla offloaded his entire stake in Panacea Biotec amounting to 5.15 per cent shareholding of the firm for Rs 118 crore, through an open market transaction

Panacea Biotech stock hits over 12-year high; zooms 83% thus far in April

Serum Institute of India Private Limited, the world's largest vaccine manufacturer by number of doses produced and sold globally, held 4.98 per cent stake in Panacea Biotech

Panacea Biotec zooms 20% as company to make 100 mn Sputnik V doses yearly

The Russian Direct Investment Fund and Panacea Biotec announced cooperation to produce 100 million doses per year of Sputnik V

Stocks to watch: Ircon Int'l, Panacea Biotech, HDFC, JSPL, Burger King

Ircon International board approved the issue of bonus shares in the ratio of 1:1

Panacea Biotec dips 13% in two days after Serum Institute cuts stake

On December 3, 2020, Serum Institute of India Private Limited sold 309,559 equity shares, representing 0.50 per cent equity of Panacea Biotec, at Rs 243.32 per share

Panacea forms JV with Refana to develop, manufacture Covid-19 vaccine

The firm is set to make 500 million doses of the vaccine, which will then be supplied to the JV (based in the Republic of Ireland).

Covid-19 crisis prompts India to look for global partners in health care

Medical devices industry has potential to attract Rs 70,000 crore in 5 years

Panacea Biotec rallies as 22 products gets GMP compliance in Ukraine

The stock up 13% to Rs 255 after the company gets certificate of GMP compliance with manufacturing authorization for 22 medicinal products from state service of Ukraine on medicines & drugs control.

Panacea Biotech up 15% on fund raising plan, demerger of real estate biz

The stock hit a 52-week high of Rs 254, up 15% on BSE in early morning trade